A smart mobile health tool that supports patients with chronic obstructive pulmonary disease (COPD) may be an effective alternative to a paper action plan for self-management of exacerbations.
A smart mobile health tool that supports patients with chronic obstructive pulmonary disease (COPD) may be an effective alternative to a paper action plan for self-management of exacerbations, according to the results of a recent study published by JMIR Mhealth Uhealth.
The researchers conducted a 2-arm randomized controlled trial, which included an intervention group of patients with COPD using the smart mHealth tool, and a control group using a paper action plan when their respiratory symptoms were worsening.
“Self-management strategies, such as the use of a written exacerbation action plan, have been shown to improve exacerbation outcomes, that is, decrease exacerbation duration, reduce hospital admissions, and decrease the impact on health status,” explained the authors. “However, many patients do not adhere to the self-management instructions in their action plans when an exacerbation is imminent and thus do not get the benefit of the favorable health effects of timely detection and subsequent intervention.”
A telephone questionnaire system was used to measure weekly respiratory symptoms and treatment actions, as well as to measure exacerbation-free time. The study also considered health status, self-efficacy, self-management behavior, health care utilization, and usability.
In total, 87 patients with COPD were recruited from primary and secondary care centers and 43 were randomly selected to be in the intervention group. The researchers found no statistically significant differences between the intervention group and the control group in exacerbation-free weeks or in health status, self-efficacy, self-management behavior, and health care utilization. However, those who used the mHealth tool valued it more for support and usability than those with the paper action plan.
“The app was not designed to replace the health care professional but to reduce patient delay. Patients evaluated the app’s usability as good and as more supportive than the paper action plan,” concluded the authors. “Although this study did not show beneficial effects of the mHealth app compared with the use of a paper action plan, based on patient’s preference, it may be a valuable alternative to a paper action plan in the management of COPD.”
The researchers suggested that future research should focus on the patients who are interested in using digital tools in their daily life since they will be who benefits most from them.
Reference
Boer L, Bischoff E, van der Heijden M, et al. A smart mobile health tool versus a paper action plan to support self-management of chronic obstructive pulmonary disease exacerbations: Randomized controlled trial [published online September 10, 2019]. JMIR Mhealth Uhealth. doi: 10.2196/14408.
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
FDA Approves Dupilumab as First Biologic Treatment for COPD
September 27th 2024The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
Read More
Social Frailty Indirectly Affects Anxiety, Depression in Patients With AECOPD Through Social Support
September 11th 2024Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact anxiety or depression but influences these conditions indirectly through social support.
Read More